In datasets based on RNA‐seq (Fig. 2B), higher expression of BTN3A1 was associated with better prognosis in bladder urothelial carcinoma (BLCA), rectum adenocarcinoma (READ), sarcoma (SARC), and UCEC. Here, BTN3A1 is linked to bladder transitional cell carcinoma.